Literature DB >> 10652371

Elastase in intestinal mucus enhances the cytotoxicity of Shiga toxin type 2d.

J F Kokai-Kun1, A R Melton-Celsa, A D O'Brien.   

Abstract

Shiga toxin variant type 2d (Stx2d) produced by some strains of Shiga toxin-producing Escherichia coli is composed of an enzymatically active A subunit and a B (binding) pentamer. The cytotoxicity of Stx2d is increased (activated) 10-1000-fold for Vero cells when the toxin is incubated with mucus obtained from the small intestine of mice. In this study we isolated an Stx2d activator and identified it as a mouse elastase with strong homology to human elastase IIIB. Moreover, commercially available porcine pancreatic elastase preparations also activated Stx2d cytotoxicity although with a lower specific activity than isolated mouse elastase. Elastase directly nicked the Stx2d A subunit to A(1) and A(2), an event that did not correlate with activation. However, elastase also reduced the size and changed the isoelectric point of the A(2) peptide, as determined by SDS-polyacrylamide gel electrophoresis and two-dimensional electrophoresis followed by Western immunoblot analysis. This elastase-mediated size and charge shift in the A(2) peptide of Stx2d occurred concurrently with activation of the toxin. Both the reduction in size of the Stx2d A(2) peptide by incubation with elastase as well as the associated activation of Stx2d cytotoxicity were fully inhibited by elastatinal, an elastase-specific inhibitor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10652371     DOI: 10.1074/jbc.275.5.3713

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Presence of activatable Shiga toxin genotype (stx(2d)) in Shiga toxigenic Escherichia coli from livestock sources.

Authors:  Kari S Gobius; Glen M Higgs; Patricia M Desmarchelier
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

2.  Shiga-toxigenic Escherichia coli-inoculated neonatal piglets develop kidney lesions that are comparable to those in humans with hemolytic-uremic syndrome.

Authors:  J F Pohlenz; K R Winter; E A Dean-Nystrom
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  The common ovine Shiga toxin 2-containing Escherichia coli serotypes and human isolates of the same serotypes possess a Stx2d toxin type.

Authors:  V Ramachandran; M A Hornitzky; K A Bettelheim; M J Walker; S P Djordjevic
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

4.  Expression of putative virulence factors of Escherichia coli O157:H7 differs in bovine and human infections.

Authors:  Rebecca A Rashid; Tami A Tabata; Melissa J Oatley; Thomas E Besser; Phillip I Tarr; Steve L Moseley
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

5.  Neutralizing antibodies to Shiga toxin type 2 (Stx2) reduce colonization of mice by Stx2-expressing Escherichia coli O157:H7.

Authors:  Krystle L Mohawk; Angela R Melton-Celsa; Cory M Robinson; Alison D O'Brien
Journal:  Vaccine       Date:  2010-05-14       Impact factor: 3.641

6.  Protection by a recombinant Mycobacterium bovis Bacillus Calmette-Guerin vaccine expressing Shiga toxin 2 B subunit against Shiga toxin-producing Escherichia coli in mice.

Authors:  Jun Fujii; Mariko Naito; Takashi Yutsudo; Sohkichi Matsumoto; Daniel P Heatherly; Takeshi Yamada; Hideyuki Kobayashi; Shin-Ichi Yoshida; Tom Obrig
Journal:  Clin Vaccine Immunol       Date:  2012-10-03

7.  Presence and characterization of shiga toxin-producing Escherichia coli and other potentially diarrheagenic E. coli strains in retail meats.

Authors:  Xiaodong Xia; Jianghong Meng; Patrick F McDermott; Sherry Ayers; Karen Blickenstaff; Thu-Thuy Tran; Jason Abbott; Jie Zheng; Shaohua Zhao
Journal:  Appl Environ Microbiol       Date:  2010-01-15       Impact factor: 4.792

8.  Characterization of Shiga toxin-producing Escherichia coli strains isolated from human patients in Germany over a 3-year period.

Authors:  Lothar Beutin; Gladys Krause; Sonja Zimmermann; Stefan Kaulfuss; Kerstin Gleier
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

9.  Shiga toxin, cytolethal distending toxin, and hemolysin repertoires in clinical Escherichia coli O91 isolates.

Authors:  Martina Bielaszewska; Franziska Stoewe; Angelika Fruth; Wenlan Zhang; Rita Prager; Jens Brockmeyer; Alexander Mellmann; Helge Karch; Alexander W Friedrich
Journal:  J Clin Microbiol       Date:  2009-04-29       Impact factor: 5.948

10.  Pathogenesis of Escherichia coli O157:H7 strain 86-24 following oral infection of BALB/c mice with an intact commensal flora.

Authors:  Krystle L Mohawk; Angela R Melton-Celsa; Tonia Zangari; Erica E Carroll; Alison D O'Brien
Journal:  Microb Pathog       Date:  2010-01-22       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.